The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis

The utility of syndecan-1 circulating levels as a biomarker in patients with previous or active COVID-19: a systematic review and meta-analysis

Abstract Background With the emergence of coronavirus disease of 2019 (COVID-19), several blood biomarkers have been identified, including the endothelial biomarker syndecan-1, a surface proteoglycan. In the current systematic review and meta-analysis, we aimed to assess the diagnostic and prognosti...

Full description

Bibliographic Details
Main Authors: Elina Ghondaghsaz, Amirmohammad Khalaji, Mitra Norouzi, Douglas D. Fraser, Sanam Alilou, Amir Hossein Behnoush
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Infectious Diseases
Subjects:
Syndecan-1
COVID-19
Diagnosis
Prognosis
Glycocalyx
Systematic review
Online Access:https://doi.org/10.1186/s12879-023-08473-9

Internet

https://doi.org/10.1186/s12879-023-08473-9

Similar Items